Aurinia Pharmaceuticals Inc. (AUPH) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.22B, a trailing price-to-earnings ratio of 7.3 and a free-cash-flow yield of 5.9%. Over the most recent reported fiscal year, revenue grew 20.4% and free cash flow per share grew 223.6%.